Jordan Dubow

Title: Innovations in Parkinson's Disease Treatment by Jordan Dubow

Introduction

Jordan Dubow is an accomplished inventor based in Glencoe, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. With a total of 2 patents, Dubow's work focuses on innovative methods and formulations that enhance patient care.

Latest Patents

Dubow's latest patents include groundbreaking methods for treating Parkinson's disease through the administration of apomorphine to the oral mucosa. These patents describe pharmaceutical unit dosage forms, specifically films that contain a first portion with particles of an acid addition salt of apomorphine and a second portion that includes a pH neutralizing agent. The films are designed to be flexible and possess a toughness greater than 100 g·mm. The methods outlined in these patents involve administering a therapeutic dose that can achieve an apomorphine plasma concentration of at least 2.64 ng/mL within 45 minutes after administration. This innovative approach allows for the identification of subjects based on their uptake levels of apomorphine.

Career Highlights

Jordan Dubow is currently associated with Sunovion Pharmaceuticals Inc., where he continues to develop and refine his innovative treatments. His work is pivotal in advancing therapeutic options for individuals suffering from Parkinson's disease.

Collaborations

Some of Dubow's notable coworkers include Scott David Barnhart and Michael Clinton Koons. Their collaborative efforts contribute to the ongoing research and development in the field of pharmaceuticals.

Conclusion

Jordan Dubow's contributions to the treatment of Parkinson's disease through innovative pharmaceutical formulations highlight the importance of research and development in improving patient outcomes. His work exemplifies the potential of targeted therapies in addressing complex medical conditions.